Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Three months of Western diet induces small intestinal mucosa alteration in TLR KO mice.

Sardi C, Luchini P, Emanuelli A, Giannoni A, Martini E, Manara LM, Sfondrini L, Kallikourdis M, Sommariva M, Rumio C.

Microsc Res Tech. 2017 Jun;80(6):563-569. doi: 10.1002/jemt.22831. Epub 2017 Jan 17.

PMID:
28094890
2.

Effect of SR58611A, a potent beta-3 adrenoceptor agonist, on cutaneous wound healing in diabetic and obese mice.

Schaeffer P, Bernat A, Arnone M, Manara L, Gallas JF, Dol-Gleizes F, Millet L, Grosset A, Herbert JM.

Eur J Pharmacol. 2006 Jan 4;529(1-3):172-8. Epub 2005 Dec 1.

PMID:
16325798
3.

Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB(1) receptors.

Landi M, Croci T, Rinaldi-Carmona M, Maffrand JP, Le Fur G, Manara L.

Eur J Pharmacol. 2002 Aug 16;450(1):77-83.

PMID:
12176112
4.

Functional assessment of neuronal cannabinoid receptors in the muscular layers of human ileum and colon.

Manara L, Croci T, Guagnini F, Rinaldi-Carmona M, Maffrand JP, Le Fur G, Mukenge S, Ferla G.

Dig Liver Dis. 2002 Apr;34(4):262-9.

PMID:
12038810
5.

Functional, biochemical and molecular biological evidence for a possible beta(3)-adrenoceptor in human near-term myometrium.

Bardou M, Loustalot C, Cortijo J, Simon B, Naline E, Dumas M, Esteve S, Croci T, Chalon P, Frydman R, Sagot P, Manara L, Morcillo EJ, Advenier C.

Br J Pharmacol. 2000 Aug;130(8):1960-6.

6.

Functional assessment of beta adrenoceptor subtypes in human colonic circular and longitudinal (taenia coli) smooth muscle.

Manara L, Croci T, Aureggi G, Guagnini F, Maffrand JP, Le Fur G, Mukenge S, Ferla G.

Gut. 2000 Sep;47(3):337-42.

7.

Inhibition by SR 59119A of isoprenaline-, forskolin- and VIP-induced relaxation of human isolated bronchi.

Naline E, Bardou M, Devillier P, Molimard M, Dumas M, Chalon P, Manara L, Advenier C.

Pulm Pharmacol Ther. 2000;13(4):167-74.

PMID:
10930355
8.

In vitro functional evidence of different neurotensin-receptors modulating the motor response of human colonic muscle strips.

Croci T, Aureggi G, Guagnini F, Manara L, Gully D, Fur GL, Maffrand JP, Mukenge S, Ferla G, Ferrara P, Chalon P, Vita N.

Br J Pharmacol. 1999 Aug;127(8):1922-8.

9.

In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum.

Croci T, Manara L, Aureggi G, Guagnini F, Rinaldi-Carmona M, Maffrand JP, Le Fur G, Mukenge S, Ferla G.

Br J Pharmacol. 1998 Dec;125(7):1393-5.

10.

In vitro inhibition of human colonic motility with SR 59119A and SR 59104A: evidence of a beta3-adrenoceptor-mediated effect.

Bardou M, Dousset B, Deneux-Tharaux C, Smadja C, Naline E, Chaput JC, Naveau S, Manara L, Croci T, Advenier C.

Eur J Pharmacol. 1998 Jul 24;353(2-3):281-7.

PMID:
9726658
11.

In vitro characterization of tachykinin NK2-receptors modulating motor responses of human colonic muscle strips.

Croci T, Aureggi G, Manara L, Emonds-Alt X, Le Fur G, Maffrand JP, Mukenge S, Ferla G.

Br J Pharmacol. 1998 Jul;124(6):1321-7.

12.

Role of tachykinins in castor oil diarrhoea in rats.

Croci T, Landi M, Emonds-Alt X, Le Fur G, Maffrand JP, Manara L.

Br J Pharmacol. 1997 Jun;121(3):375-80.

13.

Negative modulation of nitric oxide production by neurotensin as a putative mechanism of the diuretic action of SR 48692 in rats.

Croci T, Landi M, Gully D, Maffrand JP, Le Fur G, Manara L.

Br J Pharmacol. 1997 Apr;120(7):1312-8.

14.

[Medicine and doping in sports: ethical-deontologic implications].

Manara L.

Minerva Med. 1997 Jan-Feb;88(1-2):1-7. Italian. No abstract available.

PMID:
9132627
16.

Functional evidence of atypical beta 3-adrenoceptors in the human colon using the beta 3-selective adrenoceptor antagonist, SR 59230A.

De Ponti F, Gibelli G, Croci T, Arcidiaco M, Crema F, Manara L.

Br J Pharmacol. 1996 Apr;117(7):1374-6.

17.

Functional identification of rat atypical beta-adrenoceptors by the first beta 3-selective antagonists, aryloxypropanolaminotetralins.

Manara L, Badone D, Baroni M, Boccardi G, Cecchi R, Croci T, Giudice A, Guzzi U, Landi M, Le Fur G.

Br J Pharmacol. 1996 Feb;117(3):435-442.

18.

The non-peptide tachykinin NK1- and NK2-receptor antagonists SR 140333 and SR 48968 prevent castor-oil induced diarrhea in rats.

Croci T, Emonds-Alt X, Le Fur G, Maffrand JP, Manara L.

Acta Physiol Hung. 1996;84(3):273-4.

PMID:
9219603
19.

Promotion by SR 48692 of gastric emptying and defaecation in rats suggesting a role of endogenous neurotensin.

Croci T, Giudice A, Manara L, Gully D, Le Fur G.

Br J Pharmacol. 1995 Jun;115(3):383-4.

20.

Drug-induced defaecation in rats: role of central 5-HT1A receptors.

Croci T, Landi M, Bianchetti A, Manara L.

Br J Pharmacol. 1995 May;115(1):203-9.

21.

Beta 3-adrenoceptors and intestinal motility.

Manara L, Croci T, Landi M.

Fundam Clin Pharmacol. 1995;9(4):332-42. Review.

PMID:
8566932
23.

Neuronal NK3-receptors in guinea-pig ileum and taenia caeci: in vitro characterization by their first non-peptide antagonist, SR142801.

Croci T, Landi M, Emonds-Alt X, Le Fur G, Manara L.

Life Sci. 1995;57(23):PL361-6. No abstract available.

PMID:
7475959
24.

Manometric patterns of rat colonic motor activity and defecation. Effect of selective 5HT1A agonist 8-OH-DPAT.

Croci T, Basilisco G, Bassani A, Manara L.

Dig Dis Sci. 1994 Sep;39(9):1968-73.

PMID:
8082505
25.

SR 48968 selectively prevents faecal excretion following activation of tachykinin NK2 receptors in rats.

Croci T, Emonds-Alt X, Manara L.

J Pharm Pharmacol. 1994 May;46(5):383-5.

PMID:
8083813
27.

SR 48968, a neurokinin A (NK2) receptor antagonist.

Emonds-Alt X, Advenier C, Croci T, Manara L, Neliat G, Poncelet M, Proietto V, Santucci V, Soubrié P, Van Broeck D, et al.

Regul Pept. 1993 Jul 2;46(1-2):31-6. Review. No abstract available.

PMID:
8210494
28.

SR 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo.

Bachy A, Héaulme M, Giudice A, Michaud JC, Lefevre IA, Souilhac J, Manara L, Emerit MB, Gozlan H, Hamon M, et al.

Eur J Pharmacol. 1993 Jun 24;237(2-3):299-309.

PMID:
7689975
29.

Biochemical and electrophysiological properties of SR 57746A, a new, potent 5-HT1A receptor agonist.

Bachy A, Steinberg R, Santucci V, Fournier M, Landi M, Hamon M, Manara L, Keane PE, Soubrié P, Le Fur G.

Fundam Clin Pharmacol. 1993;7(9):487-97.

PMID:
8314196
30.
31.
33.

Further heterogeneity of the beta-adrenoceptor. The phenylethanolaminotetralines: new selective agonists for atypical beta-adrenoceptors.

Manara L, Bianchetti A.

Trends Pharmacol Sci. 1990 Jun;11(6):229-30. No abstract available. Erratum in: Trends Pharmacol Sci 1990 Nov;11(11):461.

PMID:
1974371
34.
35.

Results of the Pennsylvania Reproductive Associates, Pennsylvania.

Corson SL, Batzer FR, Gocial B, Eisenberg E, Huppert LC, Blotner MB, Manara L, Go KJ.

J In Vitro Fert Embryo Transf. 1988 Oct;5(5):306. No abstract available.

PMID:
3230357
36.

Comparison of the gastric antisecretory effects of ramixotidine dihydrochloride (CM 57755), a new H2 receptor antagonist, and cimetidine in dogs.

Soldani G, Lavezzo A, Bianchetti A, Manzoni L, Mengozzi G, Manara L.

Pharmacol Res Commun. 1988 Aug;20(8):663-72.

PMID:
2974998
37.

Ketoacidosis secondary to oral ritodrine use in a gestational diabetic patient: report of a case.

Halpren EW, Soifer NE, Haenel LC, Manara LR, Belsky DH.

J Am Osteopath Assoc. 1988 Feb;88(2):241-4. No abstract available.

PMID:
3127365
38.

Inhibition of rat colon motility by stimulation of atypical beta-adrenoceptors with new gut-specific agents.

Croci T, Cecchi R, Tarantino A, Aureggi G, Bianchetti A, Boigegrain R, Manara L.

Pharmacol Res Commun. 1988 Feb;20(2):147-51.

PMID:
2898155
39.
40.

Retarded cleavage following in vitro fertilization of mature human oocytes.

Chan PJ, Packin GS, Slotnick EA, Chodos WS, Manara LR, Belsky DH.

J Am Osteopath Assoc. 1987 May;87(5):368-73. No abstract available.

PMID:
3597139
42.

Dissociation of morphine withdrawal diarrhea and jumping in mice by the peripherally selective opioid antagonist SR 58002 C.

Bianchetti A, Guidice A, Nava F, Manara L.

Life Sci. 1986 Dec 15;39(24):2297-303.

PMID:
3796195
43.

Inhibition of dimaprit- and pentagastrin-induced gastric acid secretion in cats by the new histamine H2 antagonist, CM 57755.

Lavezzo A, Manzoni L, Bianchetti A, Manara L.

J Pharm Pharmacol. 1986 Nov;38(11):853-6.

PMID:
2879021
44.

The in vitro fertilization program at Cherry Hill, New Jersey.

Chan PJ, Packin GS, Slotnick EA, Chodos WS, Manara LR, Belsky DH.

J In Vitro Fert Embryo Transf. 1986 Aug;3(4):268-9. No abstract available.

PMID:
3484341
45.

Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites.

Manara L, Bianchi G, Ferretti P, Tavani A.

J Pharmacol Exp Ther. 1986 Jun;237(3):945-9.

PMID:
3012075
46.

Relative affinities of the quaternary narcotic antagonist, N-methyl levallorphan (SR 58002), for different types of opioid receptors.

Bianchetti A, Dragonetti M, Giudice A, Tarantino A, Ferrarese N, Manara L, Appelmans N, Simon EJ.

Neuropeptides. 1985 Feb;5(4-6):379-82.

PMID:
2987738
47.

The central and peripheral influences of opioids on gastrointestinal propulsion.

Manara L, Bianchetti A.

Annu Rev Pharmacol Toxicol. 1985;25:249-73. Review. No abstract available.

PMID:
3890704
48.

In vitro fertilization of human oocytes in the clinical laboratory.

Chan PJ, Manara LR, Slotnick EA, Belsky DH.

J Am Osteopath Assoc. 1984 Dec;84(4):339-42. No abstract available.

PMID:
6542556
49.

Prevention of TCDD toxicity in laboratory rodents by addition of charcoal or cholic acids to chow.

Manara L, Coccia P, Croci T.

Food Chem Toxicol. 1984 Oct;22(10):815-8.

PMID:
6541620
50.

Central and peripheral inhibition of gastrointestinal transit in rats: narcotics differ substantially by acting at either or both levels.

Peracchia F, Bianchi G, Fiocchi R, Petrillo P, Tavani A, Manara L.

J Pharm Pharmacol. 1984 Oct;36(10):699-701.

PMID:
6150093

Supplemental Content

Loading ...
Support Center